Symptom Management and Cancer Control Protocols

//Symptom Management and Cancer Control Protocols

Symptom Management and Cancer Control Protocols

Alliance A221101: A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil) to Reduce Cancer-Related Fatigue in Patients with High Grade Glioma.

EA1151: Tomosynthesis Mammographic Imaging Screening Trial (TMIST)

EAQ162CD: Longitudinal Assessment of Financial Burden in Patients with Colon or Rectal Cancer Treated with Curative Intent

PCYC-1134M: informCLL: A Disease Registry for Patients with Chronic Lymphocytic Leukemia

S0820: Phase III Double Blind Placebo-Controlled Trial of Eflomithine & Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer

S1417CD: Implementation of a Prospective Financial Impact Assessment Tool in Patients with Metastatic Colorectal Cancer

URCC 13059: A Geriatric Assessment Intervention for Patients Aged 70 and Over Receiving Chemotherapy for Advanced Cancer: Reducing Chemotherapy Toxicity in Older Adults

URCC 16092: Phase II Study of Exercise and Low-Dose Ibuprofen for Cognitive Impairment in Colorectal Cancer Patients Receiving Chemotherapy

 

2018-12-03T13:23:46+00:00